# US 2009/0156692 A1 · Use of oligomers and polymers for drug solubilization, stabilization, and delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0156692 A1
- Document ID: US20090156692A1
- Status: Published application
- Kind: A1
- Application number: 12/337,991
- Filed: 2008-12-18
- Published: 2009-06-18
- Earliest claimed: 2001-12-21
- Assignees: Soane Family Trust
- Inventors: David S. Soane; Daniel J. Suich
- Web page: https://patentgrep.com/patent/US20090156692A1

## CPC

- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 47/6907: {the form being a microemulsion, nanoemulsion or micelle}
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

The invention relates to the use of oilgomers and polymers capable of rendering insoluble drugs soluble, protecting unstable drugs, and facilitating the delivery of drugs to their site of action. This invention further relates to processes for the preparation of such oilgomers and polymers, and to compositions containing them.

## Claims

### Claim 1

A surfactant comprising a hydrophobic element having a log P value greater than 0 covalently attached to a hydrophilic element, wherein said hydrophobic element has a molecular weight of between about 10-2000 daltons, and wherein said surfactant is capable of forming a micelle that encapsulates a hydrophobic drug, said micelle having a core comprising said hydrophobic drug, wherein said core is substantially free of said hydrophobic element.

### Claim 2 (depends on 1)

The surfactant of claim 1 wherein said hydrophobic element is a small molecule or an oligomer or polymer.

### Claim at position 3

3-4. (canceled)

### Claim 5 (depends on 2)

The surfactant of claim 2 wherein said oligomer or polymer is selected from the group consisting of peptides having hydrophobic side chains and unnatural stepwise oligomers having hydrophobic side chains.

### Claim 6

(canceled)

### Claim 7 (depends on 2)

The surfactant of claim 2 wherein said oligomer or polymer is a short peptide comprising less than about 20 amino acids.

### Claim at position 7

8-12. (canceled)

### Claim 13 (depends on 2)

The surfactant of claim 2 wherein said small molecule is selected from the group consisting of cholesterol, cholesterol derivatives, bile acids, bile acid derivatives, steroidal sapogenins, triterpenoid sapogenins, steroidal sapogenin derivatives, triterpenoid sapogenin derivatives, steroid derivatives, amino acids, and mixtures thereof.

### Claim at position 9

14-20. (canceled)

### Claim 21 (depends on 1)

The surfactant of claim 1 wherein said hydrophilic element further comprises at least one binding element.

### Claim 22

(canceled)

### Claim 23 (depends on 1)

The surfactant of claim 1 wherein said hydrophilic element further comprises at least one transport element.

### Claim 24

(canceled)

### Claim 25 (depends on 1)

The surfactant of claim 1 wherein said hydrophilic element further comprises linkers that are capable of being cleaved under physiological conditions.

### Claim at position 15

26-30. (canceled)

### Claim 31 (depends on 1)

The surfactant of claim 1 wherein said surfactant is a permeation-enhancing molecule.

### Claim at position 17

32-73. (canceled)

### Claim 74

A surfactant comprising a first hydrophilic element covalently attached to a first end of a hydrophobic element and a second hydrophilic element covalently attached to a second end of said hydrophobic element, wherein said first and second hydrophilic elements are different in size and/or shape, and wherein said surfactant is capable of forming a micelle that has a core comprising a hydrophilic drug.

### Claim 75 (depends on 74)

The surfactant of claim 74 wherein said hydrophobic element is a small molecule or an oligomer or polymer.

### Claim at position 20

76-79. (canceled)

### Claim 80 (depends on 75)

The surfactant of claim 75 wherein said small molecule is selected from the group consisting of cholesterol, cholesterol derivatives, bile acids, bile acid derivatives, steroidal sapogenins, triterpenoid sapogenins, steroidal sapogenin derivatives, triterpenoid sapogenin derivatives, steroid derivatives, amino acids, and mixtures thereof.

### Claim at position 22

81-86. (canceled)

### Claim 87 (depends on 74)

The surfactant of claim 74 wherein said second hydrophilic element further comprises at least one binding element.

### Claim 88

(canceled)

### Claim 89 (depends on 74)

The surfactant of claim 74 wherein said second hydrophilic element further comprises at least one transport element.

### Claim at position 26

90-102. (canceled)

### Claim 103 (depends on 74)

A micelle for encapsulating a hydrophilic drug comprising a plurality of surfactants of claim 74.

### Claim at position 28

104-137. (canceled)

### Claim 138

An oligomer, polymer, and/or mixtures thereof for the protection of a protein drug comprising at least one recognition element covalently attached to a hydrophilic element, wherein said recognition element or elements interact noncovalently with said protein drug to form a complex in which said protein drug is protected from degradation, recognition by the immune system, and/or renal excretion.

### Claim 139 (depends on 138)

The oligomer, polymer, and/or mixtures thereof of claim 138 wherein said protein drug has an active site that is not obstructed by said oligomer or polymer, thereby maintaining biological activity of said protein drug in said complex.

### Claim 140 (depends on 138)

The oligomer, polymer, and/or mixtures thereof of claim 138 having a plurality of recognition elements, wherein each recognition element binds to a mutually distinct site on said protein drug.

### Claim 141 (depends on 138)

The oligomer, polymer, and/or mixtures thereof of claim 138 wherein said recognition element or elements are covalently attached to at least one reactive chemical group or reactive linker, wherein said reactive chemical group or said reactive linker is capable of reacting with at least one functional group on said protein drug, and wherein said reactive chemical group or reactive linker is capable of forming at least one covalent linkage between said recognition element or elements and said protein drug.

### Claim at position 33

142-163. (canceled)

### Claim 164 (depends on 138)

A complex comprising the composition of claim 138.

### Claim at position 35

165-189. (canceled)
